MSMitsuhiro Sado

Mitsuhiro Sado

*This is an algorithmically generated author record based on publicly available information.

Mitsuhiro Sado has a total of 126 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Association between nonrestorative sleep and increased healthcare costs: a 6-year cohort study

    by Shota Matsunaga, Mitsuhiro Sado, Yoshitaka Kaneita, Norio Sasaki, Katsutoshi Tanaka, Kenichi Kuriyama

    Nonrestorative sleep (NRS) refers to the subjective experience of not feeling refreshed after sleeping. Although associations between NRS and mental and physical health have been reported, their relationship with long-term healthcare costs has not been examined. This study investigated whether NRS is associated with increased long-term healthcare costs using a large-scale cohort dataset from Japan. We analyzed the annual health screening and medical claims data of 117,049 individuals enrolled in a health insurance association for civil engineering and construction workers. NRS was assessed in the 2018 health screening using a single item: “Do you feel refreshed after a typical night’s sleep?” Annual healthcare costs were calculated using medical claims data from fiscal years (FY) 2018 to 2023. Mixed-effects models for repeated measures, including interaction terms, were used to examine the association between NRS and healthcare costs over time. Sex-stratified analyses were also performed. At baseline, 45.7% of participants reported NRS. From FY 2020 onward, healthcare costs were significantly higher in the NRS group than in the restorative sleep (RS) group. In FY 2023, the cost difference was JPY 18,468 (95% CI: 7,306 to 29,630). Interaction analysis revealed that the cost gap between the NRS and RS groups widened significantly over time. Similar trends were observed in the sex-stratified analysis. NRS is significantly associated with increased long-term healthcare costs, suggesting an important medical and economic impact. Screening for NRS during routine health checkups and providing early interventions may be beneficial in reducing healthcare costs.


  • Open Access

    Scoring System for the Japanese Version of the ICECAP-A [Corrigendum]

    by Mitsuhiro Sado, Kengo Nagashima, Akihiro Koreki

    Corrigendum for the article Scoring System for the Japanese Version of the ICECAP-A

  • Open Access

    Scoring System for the Japanese Version of the ICECAP-A

    by Mitsuhiro Sado, Kengo Nagashima, Akihiro Koreki

    This study aimed to develop a value set for the Japanese version of the Investigating Choice Experiments CAPability Measure for Adults (ICECAP-A). A total of 400 participants were recruited. Survey 1, conducted utilizing a self-report format, collected demographic data and responses to well-being scales, including the ICECAP-A, the Investigating Choice Experiments CAPability Measure for Older People (ICECAP-O), and the EuroQol 5 Dimensions (EQ-5D), among others. Participants who completed Survey 1 were invited to participate in Survey 2. In Survey 2, an interview-based assessment, participants engaged in best-worst scaling, where they identified the most and least favorable situations in each of the 16 hypothetical scenarios. A mixed-mixed multinomial logit (MM-MNL) model was utilized to estimate preference parameters, accounting for individual heterogeneity and latent classes. The estimated parameters and tariffs indicated that all five attributes contributed to an individual's capability for well-being, consistent with prior studies. The attributes were ranked in order of importance as follows: "enjoyment" (24.8% of the space), "attachment" (22.1%), "stability" (19.5%), "autonomy" (17.9%), and "achievement" (15.6%). For "enjoyment" and "attachment", the differences between levels 1 and 2 and between levels 2 and 3 were equally large. In contrast, for all other attributes, the greatest differences were observed between levels 1 and 2. Across all attributes, the differences between levels 3 and 4 were comparatively smaller. We developed a Japanese version of the ICECAP-A and demonstrated the feasibility of utilizing best-worst scaling in a non-European context. This approach allows for a more precise evaluation of quality of life (QoL) among individuals with chronic conditions, caregivers, and the general population. Future research should assess the scale's sensitivity in capturing changes in capability over time.


  • Open Access

    Cost-effectiveness analysis of mindfulness-based cognitive therapy in patients with anxiety disorders in secondary mental health care settings alongside a randomized controlled trial

    by Mitsuhiro Sado, Akihiro Koreki, Akira Ninomiya, Chika Kurata, Sunre Park, Daisuke Fujisawa, Teppei Kosugi, Maki Nagaoka, Atsuo Nakagawa, Masaru Mimura

    Introduction: Anxiety disorder is one of the most prevalent mental disorders. Mindfulness-based cognitive therapy (MBCT) is effective for treating anxiety disorders. However, no studies have investigated the cost-effectiveness of MBCT for anxiety disorders. We aimed to conduct a cost-effectiveness analysis alongside a randomized controlled trial (RCT) to clarify the cost-effectiveness of MBCT for anxiety disorders.Methods: A cost-effectiveness analysis alongside an RCT was conducted for 8 weeks in 40 patients with anxiety disorders at a university hospital. Patients (1) aged 20–75 years; (2) who were diagnosed with panic disorder/agoraphobia or social anxiety disorder based on the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, criteria; and (3) who provided written consent were analyzed. The participants were allocated randomly (1:1 ratio) to the augmented MBCT group (i.e., MBCT plus treatment as usual [TAU]) or TAU (waitlist control) group. The cost-effectiveness was assessed using the incremental cost-effectiveness ratio (ICER), which is the ratio of the incremental costs divided by the incremental state-trait anxiety inventory- state (STAI-S), state-trait anxiety inventory- trait (STAI-T), and quality-adjusted life years (QALYs). The QALYs were estimated using The Japanese version of EuroQoL five-dimensional 3-level questionnaire. The unit cost data were derived from the government-regulated fees. This study was conducted from a public healthcare insurance perspective. No discount rates were considered.Results: A total of 38 participants with complete data were included in the analysis. The MBCT was JPY 13,885 more than the cost of TAU and was associated with a STAI-S, STAI-T, and QALY increase of 10.13, 12.00, 0.009 respectively. The ICER were JPY 1,371 (USD13) per STAI-S, JPY 1,157 (USD 11) per STAI-T, and JPY 1,566,357 (USD 14,940) per QALY respectively. MBCT had an 77.5% probability of being cost-effective at a willingness to pay threshold in Japan (JPY 5,000,000 per QALY). The results of the four one-way sensitivity analyses supported the robustness of the base-case analysis findings.Discussion: Augmented MBCT for anxiety disorders is cost-effective compared with TAU post-treatment from a public healthcare insurance perspective. Future studies should include long-term observations, and analysis from a societal perspective.


  • Open Access

    The association between salivary IL-6 and poor sleep quality assessed using Apple watches in stressed workers in Japan

    by Akihiro Koreki, Mitsuhiro Sado, Yasue Mitsukura, Hisateru Tachimori, Anna Kubota, Yoshiaki Kanamori, Manae Uchibori, Shiyori Usune, Akira Ninomiya, Ryutaro Shirahama, et al.

    Insomnia is a major concern among stressed workers worldwide. Although stress generally has a detrimental effect on sleep quality, the impact of biological stress, especially the immunological stress response, on sleep quality is not yet fully understood. Stressed workers were recruited through a screening process using a Brief Job Stress Questionnaire. The participants were asked to complete various occupation-related questionnaires. Additionally, saliva samples were collected to assess interleukin-6 (IL-6) levels as an immunological stress response. Subsequently, they were asked to wear an Apple Watch to record their sleep pattern for one week. Their sleep architecture was estimated using a previously published and validated method. Finally, data from 73 participants were analyzed. Our multivariable analysis revealed that shorter durations of slow-wave sleep (non-rapid eye movement sleep stage 3) were significantly associated with elevated IL-6 levels (p = 0.005) and greater daytime sleepiness (p = 0.002) after controlling for total sleep time. Our finding that a higher immunological stress response is associated with poor sleep quality contributes to a better understanding of insomnia in stressed workers and emphasizes the importance of stress management in this population.


  • Open Access

    Live two‐way video versus face‐to‐face treatment for depression, anxiety, and obsessive‐compulsive disorder: A 24‐week randomized controlled trial

    by Taishiro Kishimoto, Shotaro Kinoshita, Momoko Kitazawa, Akitoyo Hishimoto, Takeshi Asami, Akira Suda, Shogyoku Bun, Toshiaki Kikuchi, Mitsuhiro Sado, Akihiro Takamiya, et al.

    Aim: Live two‐way video, easily accessible from home via smartphones and other devices, is becoming a new way of providing psychiatric treatment. However, lack of evidence for real‐world clinical setting effectiveness hampers its approval by medical insurance in some countries. Here, we conducted the first large‐scale pragmatic, randomized controlled trial to determine the effectiveness of long‐term treatment for multiple psychiatric disorders via two‐way video using smartphones and other devices, which are currently the primary means of telecommunication.Methods: This randomized controlled trial compared two‐way video versus face‐to‐face treatment for depressive disorder, anxiety disorder, and obsessive‐compulsive disorder in the subacute/maintenance phase during a 24‐week period. Adult patients with the above‐mentioned disorders were allocated to either a two‐way video group (≥50% video sessions) or a face‐to‐face group (100% in‐person sessions) and received standard treatment covered by public medical insurance. The primary outcome was the 36‐Item Short‐Form Health Survey Mental Component Summary (SF‐36 MCS) score. Secondary outcomes included all‐cause discontinuation, working alliance, adverse events, and the severity rating scales for each disorder.Results: A total of 199 patients participated in this study. After 24 weeks of treatment, two‐way video treatment was found to be noninferior to face‐to‐face treatment regarding SF‐36 MCS score (48.50 vs 46.68, respectively; p < 0.001). There were no significant differences between the groups regarding most secondary end points, including all‐cause discontinuation, treatment efficacy, and satisfaction.Conclusion: Two‐way video treatment using smartphones and other devices, was noninferior to face‐to‐face treatment in real‐world clinical settings. Modern telemedicine, easily accessible from home, can be used as a form of health care.


  • Open Access

    Economic Evaluation Alongside a Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy in Healthy Adults

    by Maki Nagaoka, Akihiro Koreki, Teppei Kosugi, Akira Ninomiya, Masaru Mimura, Mitsuhiro Sado

    Purpose: This study aimed to conduct an economic evaluation of mindfulness-based cognitive therapy (MBCT) in healthy participants by performing cost-utility analysis (CUA) and cost-benefit analysis (CBA). Patients and Methods: CUA was carried out from a healthcare sector perspective and CBA was from the employer’s perspective in parallel with a randomized controlled trial. Of the 90 healthy participants, 50 met the inclusion criteria and were randomized to the MBCT group (n = 25) or wait-list control group (n = 25). In the CUA, intervention costs and healthcare costs were included, while the mean difference in the change in quality-adjusted life years (QALYs) between the baseline and 16-week follow-up was used as an indicator of effect. Incremental cost-effectiveness ratio (ICER) was produced, and uncertainty was addressed using non-parametric bootstrapping with 5000 replications. In the CBA, the change in productivity losses was reflected as a benefit, while the costs included intervention and healthcare costs. The net monetary benefit was calculated, and uncertainty was handled with 5000 bootstrapping. Healthcare costs were measured with the self-report Health Service Use Inventory. The purchasing power parity in 2019 was used for currency conversion. Results: In the CUA, incremental costs and QALYs were estimated at JPY 19,700 (USD 189) and 0.011, respectively. The ICER then became JPY 1,799,435 (USD 17,252). The probability of MBCT being cost-effective was 92.2% at the threshold of 30,000 UK pounds per QALY. The CBA revealed that MBCT resulted in increased costs (JPY 24,180) and improved work productivity (JPY 130,640), with a net monetary benefit of JPY 106,460 (USD 1021). The probability of the net monetary benefit being positive was 69.6%. Conclusion: The results suggested that MBCT may be more cost-effective from a healthcare sector perspective and may be cost-beneficial from the employer’s perspective.


  • Open Access

    Formulation of a Mapping Formula to Estimate Well-Being Utility from Clinical Subjective Well-Being Scales

    by Akihiro Koreki, Maki Nagaoka, Akira Ninomiya, Masaru Mimura, Mitsuhiro Sado

    Purpose: Cost-effective analysis is one of the most useful analyses for political decision-making in medicine under a limited budget. Although the data of the ICEpop CAPability measure for Adults (ICECAP-A) is sometimes essential for the measurement of cost effectiveness, such data are often lacking in most clinical trials. Therefore, a conversion formula (ie mapping) derived from the values of clinical assessment scales into utility is required. Patients and Methods: We used an internet survey where 500 general residents were asked to fill in four kinds of self-reported questionnaires [ICECAP-A, the Satisfaction with Life Scale (SWLS), Flourishing Scale (FS), and the Scale of Positive and Negative Experience (SPANE)]. A beta regression was conducted with the utility assessed by ICECAP-A as a dependent variable. Results: We developed several mapping formulae depending on available questionnaires. These mapping formulae were well-validated in our validation sample. The models using a greater number of questionnaires tended to show better mapping. Conclusion: The mapping function of our formula was within the range of other reported mapping studies. We believe this formula is useful for cost effective analyses of several trials where utility data are lacking.


  • Open Access

    Effectiveness and Cost-effectiveness of Online Brief Mindfulness-based Cognitive Therapy for the Improvement of Productivity in the Workplace: Study Protocol for a Randomized Controlled Trial

    by Mitsuhiro Sado, Masashi Yamada, Akira Ninomiya, Maki Nagaoka, Naho Goto, Akihiro Koreki, Atsuo Nakagawa, Zindel Segal, Masaru Mimura

    Background: Numerous studies have demonstrated the effectiveness of mindfulness-based programs (MBPs) among both clinical and nonclinical populations. These data document positive impacts in the workplace, including reducing perceived stress and burnout and increasing well-being. However, the effectiveness for productivity, which is of most interest to managers and administrators, is still unclear. In addition, MBPs in the workplace tend to be modified by reducing the number of the program sessions or delivering content online to improve accessibility. To date, however, the impact of MBPs that feature these modifications on productivity in the workplace has not been investigated. Objective: The study aims to investigate the effectiveness and cost-effectiveness of online-delivered brief mindfulness-based cognitive therapy (bMBCT) for improving productivity and other work-related outcomes among healthy workers compared to the waitlist control. Methods: We will conduct a 4-week randomized controlled trial (RCT) with a 6-month follow-up. Employees are included in the study if they (1) are between the ages of 20 and 65 years and (2) work longer than 30 hours weekly. Employees are randomly allocated to either the bMBCT group or the waitlist control group. The primary outcome of the study is the mean difference of productivity measured by the World Health Organization Health and Work Performance Questionnaire (WHO-HPQ) between the groups at 4, 16, and 28 weeks. Secondary outcomes include several clinical outcomes and health economics evaluation. Results: We started recruiting participants in August 2021, and the intervention began in October 2021. A total of 104 participants have been enrolled in the study as of October 2021. The intervention is scheduled to be completed in December 2023. Data collection will be completed by the end of January 2024. Conclusions: The novelty of the study is that (1) it will investigate bMBCT’s effectiveness on productivity, which is still unclear, and (2) samples are recruited from 3 companies in different industries. The limitations of the study are that (1) all measures assessed are in self-report format and (2) we lack an active control group. This study has the potential to provide new data on the relationship between MBPs and occupational health and productivity. Trial Registration: University Hospital Medical Information Network Clinical Trials Registry UMIN000044721; https://tinyurl.com/4e2fh873 International Registered Report Identifier (IRRID): DERR1-10.2196/36012